The 2,000 patient-study will use Fluidigm’s Mass Cytometry technology.
- From High Stakes to High Speed
- Don’t Miss These Solutions from Virtual Engineering Week Exhibitors
- Well Health Brings Home $45M in Series C Round
- GT Medical Brings in $16M to Change Tumor Treatment Paradigm
- Let’s Talk Medtech: Here’s a Tool Every Medical Device Rep Needs
- GE Healthcare Acquires Prismatic Sensors for Undisclosed Sum